A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer

Conditions: Breast Cancer Interventions: Drug: Anlotinib Sponsors: The First Hospital of Jilin University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials